Evercore ISI analyst Vijay Kumar raised the firm’s price target on Danaher (DHR) to $254 from $250 and keeps an Outperform rating on the shares. Given Danaher had telegraphed FY26 color on its Q3 call and had a Q4 pre-announcement, the recent quarterly call was generally in-line with no major surprises, the analyst tells investors in a research note. The firm thought the guidance had some cushion given there were no cap deployment assumptions, adding that there is a potential for life sciences end market turning.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHR:
- Danaher price target raised to $270 from $265 at BofA
- Danaher: Robust Q4 Beat and Credible 2026 Growth Outlook Underpin Buy Rating
- Morning Movers: Starbucks rises after Q1 results and FY26 guidance
- Danaher sees FY26 EPS $8.35-$8.50, consensus $8.42
- Danaher reports Q4 adjusted EPS $2.23, consensus $2.19
